Boston Scientific (NYSE:BSX) has acquired privately held EMcision Limited for an undisclosed sum. The London- and Montreal-based company's lead product is the Habib EndoHPB probe, a endoscopic bipolar radiofrequency device that coagulates tissue in the GI tract. It is used to treat patients with pancreaticobiliary cancers.
The transaction will be immaterial to Boston's 2018 GAAP and non-GAAP earnings and accretive thereafter.
MG+M The Law Firm (MG+M) is pleased to announce that it has elevated attorneys Stephanie M. Chesney
Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm
BayCoast Bank is delighted to announce Nicole Almeida as Senior Vice President, Chief Diversity Officer (CDO)
BayCoast Bank is pleased to announce Robert Bergdoll of Attleboro, Massachusetts, as First Vice President Marketing Director
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
